Table: Green Peptide -Q1 parent results

BrightPath Biotherapeutics Co

15/08/2016 07:00

Aug 15 (Reuters)-  
             Green Peptide Co., Ltd.  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended        Year to   
                Jun 30, 2016        Jun 30, 2015      Mar 31, 2017   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales            193 mln             206 mln           406 mln     
                 (-6.4 pct)                            (-50.5 pct)   
  Operating     loss 187 mln        loss 290 mln        loss 1.31    
  Recurring     loss 190 mln        loss 277 mln        loss 1.31    
  Net           loss 190 mln        loss 278 mln        loss 1.31    
  EPS           loss 5.97 yen      loss 10.99 yen    loss 41.14 yen  
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
   
  NOTE - Green Peptide Co., Ltd..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T 
  ((Tokyo Headline News Desk +813 6441 1812))